On May 5, 2017, the Quebec Government released its Life Sciences Strategy 2017-2027 – Innovation comes to life. The CTS welcomes this announcement and the government’s desire to make Quebec a leader in this sector in North America.

Recognizing the full potential of the life sciences sector, and particularly medical technologies to contribute to economic development, this new strategy calls on the entire ecosystem to continue to structure both research and development and those that are designed to validate and market innovations. It also aims to attract additional private investment, notably by optimizing the venture capital financing chain.

For Guillaume Hervé, CTS Board Chair: “Quebec has major healthcare networks and academics as well as a dynamic community of investors able to develop a highly creative environment in the field of medical technologies. This government strategy and the tools associated with it are remarkably responsive to the needs identified by the actors of the ecosystem ”

The CTS would also like to highlight the relevance of the creation of the Office of Innovation in Health and Social Services and the creation of the Health Collaborations Accelerator Fund. Thanks to these structures, the innovation of Quebec businesses will be able to benefit Quebeckers more in their own healthcare network. In addition, this will allow entrepreneurs to better validate their products and they will benefit from a true technological showcase to propel themselves on the international markets.

Finally, the CTS welcomes the fact that attention is being paid to the venture capital funding chain of life sciences companies, linked to the innovation chain.

With the Quebec Life Sciences Strategy, the Government of Quebec sets ambitious targets and proposes ways to achieve them. The CTS is committed to continuing to support this approach and to being a leading partner in the realization of this strategy for the dynamic development of the life sciences sector in Quebec.


About CTS

CTS is an accelerator of companies in the field of medical technologies which offers them to develop faster and increases their chances of success. The goal of the CTS is to offer start-up companies a unique proposition with structured framework that allows them to focus on developing their technology, reaching market dynamics and gaining the visibility they need to start and develop internationally


For additional information (journalists only)

CTS Romain Lortille Bruel

Director of Business Development514 274-1001 ou 514 808-9775